HALO prostate study for men with early prostate cancer
Part of Brain & nervous system, Cancer, Heart & circulation, Injuries & trauma, Mental health clinical trials.
This trial studies HALO, a new “human analytics” approach, in men with early-stage prostate cancer. It may help doctors better assess or guide care using MRI and biopsy findings, before or around initial treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 45 or older
- You have been newly diagnosed (no prior treatment) with prostate adenocarcinoma
- Your cancer is early stage (T1c or T2a) with Gleason score 7 (3+4 or 4+3) or less
- Your prostate biopsy shows no more than 3 cancer-containing biopsy cores, and PSA density is 0.375 or less
- You can have an MRI safely (no metal/implants or other MRI-incompatible items) and you can tolerate anesthesia/sedation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial uses repeated MRI scans to monitor prostate lesions that have a low chance of being aggressive cancer. It is for people who have suspicious spots but whose initial biopsies did not find high-grade cancer.
This trial tests how a special MRI scan (with multiple measurements) may help men with low-risk prostate cancer who are monitoring it closely instead of treating right away. It may help doctors better understand the cancer’s status during active surveillance.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This trial is testing whether a single MRI scan can replace multiple tests to stage prostate cancer. It is for people with more aggressive or advanced prostate cancer who are planning active treatment like surgery or radiation.
This trial is testing a more personalized way to perform prostate biopsies. It's for men who have a suspicious finding on exam or imaging, or a higher PSA level, and who have had a special MRI that suggests cancer. The goal is to improve accuracy and reduce unnecessary biopsies.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.